{"title": "PPT - TROMBOPATIAS PowerPoint Presentation, free download - ID:3848671", "author": "Kaelem", "url": "https://www.slideserve.com/kaelem/trombopatias", "hostname": "slideserve.com", "description": "TROMBOPATIAS. DIAGNOSTICO. ANEMIA APL\u00c1SICA. NO ESPLENOMEGALIA PANCITOPENIA MARCADA ANEMIA MARCADA NORMOCITICA NORMOCR\u00d3MICA. EN EL F.S.P. NO HAY ERITROBLASTOS. ADE NORMAL. RETICULOCITOS AUSENTES. NEUTROPENIA SEVERA AUSENCIA DE CELULAS INMADURAS. HIPOPLASIA MEGACAROCITICA.", "sitename": "SlideServe", "date": "2014-09-03", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "650 likes | 993 Views\nTROMBOPATIAS. DIAGNOSTICO. ANEMIA APL\u00c1SICA. NO ESPLENOMEGALIA PANCITOPENIA MARCADA ANEMIA MARCADA NORMOCITICA NORMOCR\u00d3MICA. EN EL F.S.P. NO HAY ERITROBLASTOS. ADE NORMAL. RETICULOCITOS AUSENTES. NEUTROPENIA SEVERA AUSENCIA DE CELULAS INMADURAS. HIPOPLASIA MEGACAROCITICA.\nE N D\n[TROMBOPATIAS](https://image2.slideserve.com/3848671/trombopatias-l.jpg) DIAGNOSTICO [ANEMIA APL\u00c1SICA](https://image2.slideserve.com/3848671/anemia-apl-sica-l.jpg) \u2022 NO ESPLENOMEGALIA \u2022 PANCITOPENIA MARCADA \u2022 ANEMIA MARCADA NORMOCITICA NORMOCR\u00d3MICA. \u2022 EN EL F.S.P. NO HAY ERITROBLASTOS. \u2022 ADE NORMAL. \u2022 RETICULOCITOS AUSENTES. \u2022 NEUTROPENIA SEVERA \u2022 AUSENCIA DE CELULAS INMADURAS [HIPOPLASIA MEGACAROCITICA](https://image2.slideserve.com/3848671/hipoplasia-megacarocitica-l.jpg) \u2022 ANEMIA DE FANCONI. \u2022 SINDROME TROMBOCITOPENIA \u2013 AUSENCIA DEL RADIO (TAR) \u2022 SINDROME DE WISCOTT \u2013 ALDRICH \u2022 ANOMALIA DE MAY HEGGLIN [ANOMALIA DE MAY-HEGGLIN](https://image2.slideserve.com/3848671/anomalia-de-may-hegglin-l.jpg) \u2022 PLAQUETAS DE GRAN TAMA\u00d1O (HASTA 20u). \u2022 CUERPOS DE D\u00d6HLE. \u2022 ASINTOMATICA. \u2022 FUNCION PLAQUETARIA NORMAL. \u2022 AUMENTO DE MEGACARIOCITOS. \u2022 ULTRAESTRUCTURA ANORMAL. \u2022 MADURACI\u00d3N Y/O FRAGMENTACION ANORMAL. [SINDROME TAR](https://image2.slideserve.com/3848671/sindrome-tar-l.jpg) \u2022 TROMBOCITOPENIA NEONATAL. \u2022 GRANULOS DENSOS INSUFICIENTES. [HIPOPLASIA NEONATAL](https://image2.slideserve.com/3848671/hipoplasia-neonatal-l.jpg) \u2022 INFECCI\u00d3N POR RUBEOLA. \u2022 EFECTO CITOT\u00d3XICO DIRECTO MEGACARIOCITOS DE LA M\u00c9DULA FETAL. \u2022 MENOS DE 70000/uL. \u2022 DISMINUCI\u00d3N MARCADA O AUSENCIA DE MEGACARIOCITOS. [TROMBOPOYESIS INEFICAZ](https://image2.slideserve.com/3848671/trombopoyesis-ineficaz-l.jpg) \u2022 ANEMIA MEGALOBLASTICA \u2022 PRODUCCION PLAQUETARIA INEFICAZ. \u2022 MEGACARIOCITOS ANORMALES. \u2022 PLAQUETAS GRANDES CON VIDA MEDIA DISMINUIDA Y FUNCI\u00d3N ANORMAL. \u2022 TROMBOCITOPENIA LEVE. [OTRAS CAUSAS](https://image2.slideserve.com/3848671/otras-causas-l.jpg) \u2022 VIRUS VIVOS (VACUNA SARAMPION) VACUOLIZACION DEGENERATIVA DE LOS MEG 6-8 DIAS DESPUES. \u2022 CITOMEGALOVIRUS. \u2022 VARICELA. \u2022 RUBEOLA. \u2022 EPSTEIN BARR. \u2022 VIRUS FIEBRE HEMORR\u00c1GICA. \u2022 M\u00c9DULA \u00d3SEA INFILTRADA POR C\u00c9LULAS MALIGNAS. [PTI](https://image2.slideserve.com/3848671/slide14-l.jpg) \u2022 30-80x103/uL. \u2022 PLAQUETAS MORFOLOGICAMENTE NORMALES O GRANDES. \u2022 VPM AUMENTADO. \u2022 LEUCOCITOS Y ERITROCITOS NORMALES. \u2022 HIPERPLASIA MEGACARIOCITICA. [PTI INDUCIDA POR FARMACOS](https://image2.slideserve.com/3848671/pti-inducida-por-farmacos-l.jpg) \u2022 TROMBOCITOPENIA GRAVE. \u2022 MENOS DE 10x103/uL. \u2022 CANTIDAD DE MEGACARIOCITOS NORMAL A ELEVADA. [TROMBOCITOPENIA INDUCIDA POR HEPARINA.](https://image2.slideserve.com/3848671/trombocitopenia-inducida-por-heparina-l.jpg) \u2022 TROMBOCITOPENIA CON TROMBOS INTRAVASCULARES. \u2022 AGREGACION PLAQUETARIA. \u2022 PRUEBA DE LIBERACI\u00d3N DE SEROTONINA RADIOACTIVIDAD. \u2022 PRUEBA DE PLAQUETAS LAVADAS \u2022 INMUNOENSAYO Ac. anti-FP4. [CID](https://image2.slideserve.com/3848671/slide22-l.jpg) \u2022 HEMOLISIS MICROANGIOPATICA. \u2022 DEP\u00d3SITO DE TROMBOS (PLAQ+FIB). \u2022 TROMBOCITOPENIA INTENSA. \u2022 FACTORES V, VIII Y FIB DISMINUIDOS. \u2022 DIMERO D POSITIVO. [CRITERIOS DIAGNOSTICOS-PTT](https://image2.slideserve.com/3848671/criterios-diagnosticos-ptt-l.jpg) \u2022 MUJERES 30 \u2013 40 A\u00d1OS. \u2022 HEMOLISIS. \u2022 TROMBOCITOPENIA. \u2022 DISFUNCI\u00d3N NEUROL\u00d3GICA. \u2022 FIEBRE. \u2022 INSUFICIENCIA RENAL PROGRESIVA. \u2022 OCLUCIONES TROMBOTICAS [DATOS DE LABORATORIO](https://image2.slideserve.com/3848671/datos-de-laboratorio-l.jpg) \u2022 LDH Y BILIRRUBINA NO CONJUGADA AUMENTADA. \u2022 HAPTOGLOBINA BAJA. \u2022 HGB MENOR A 10 g. \u2022 RETICULOCITOS AUMENTADOS. \u2022 ERITROCITOS NUCLEADOS. \u2022 RECUENTO LEUCOCITARIO INCREMENTADO. \u2022 PROTEINURIA Y HEMATURIA. \u2022 HEMOGLOBINA Y HEMOSIDERINURIA. \u2022 PT-PTT-TT Y FIB NORMALES. \u2022 PDF Y DD AUMENTADOS. [CRITERIOS DIAGNOSTICOS-SUH](https://image2.slideserve.com/3848671/criterios-diagnosticos-suh-l.jpg) \u2022 NI\u00d1OS PEQUE\u00d1OS. \u2022 ANEMIA HEMOLITICA MICROANGIOP\u00c1TICA. \u2022 PLAQUETOPENIA. \u2022 INSUFICIENCIA RENAL AGUDA. \u2022 VEROCITOTOXINA ENDOTELIO CAPILAR RENAL. \u2022 E. COLI, SHIGELLA. [DATOS DE LABORATORIO](https://image2.slideserve.com/3848671/datos-de-laboratorio1-l.jpg) \u2022 ESQUISTOCITOS \u2022 SUPERVIVENCIA DE PLAQUETAS REDUCIDA. \u2022 LEUCOCITOSIS MODERADA. \u2022 ERITTROBLASTOS \u2022 PT, PTT Y TT NORMALES. \u2022 PDF AUMENTADOS. \u2022 ORINA PROTEINAS Y ERITROCITOS [AHMA CON PLAQUETOPENIA](https://image2.slideserve.com/3848671/ahma-con-plaquetopenia-l.jpg) \u2022 QUIMIOTERAPIA. \u2022 ASOCIADA CON TRANSPLANTES. [TROMBOCITOSIS](https://image2.slideserve.com/3848671/trombocitosis-l.jpg) REACTIVA. \u2022 ASOCIADA A HEMORRAGIA O CIRUGIA. \u2022 POSESPLENECTOMIA. \u2022 ANEMIA FERROPENICA. \u2022 ENFERMEDAD INFLAMATORIA. \u2022 POR EJERCICIO. \u2022 POR REBOTE. [TROMBOCITOSIS](https://image2.slideserve.com/3848671/trombocitosis1-l.jpg) TRANSTORNOS MIELOPROLIFERATIVOS \u2022 POLICITEMIA VERA. \u2022 LEUCEMIA MIELOIDE CR\u00d3NICA. \u2022 METAPLASIA MIELOIDE. \u2022 TROMBOCITOPENIA ESENCIAL. [TROMBOCITEMIA ESENCIAL](https://image2.slideserve.com/3848671/trombocitemia-esencial-l.jpg) \u2022 TRASTORNO MONOCLONAL. \u2022 RTO PLAQUETAS MAYOR 1 MILLON/uL. \u2022 POLIFERACI\u00d3N DESCONTROLADA DE LOS MEGACARIOCITOS EN M.O. \u2022 ADULTOS Y PERSONAS MAYORES (HOMBRES Y MUJERES). \u2022 HEMORRAGIA, DISFUNCI\u00d3N PLAQUETARIA Y TROMBOSIS. \u2022 TIEMPO DE SANGRIA NORMAL. [TROMBOCITEMIA ESENCIAL](https://image2.slideserve.com/3848671/trombocitemia-esencial1-l.jpg) \u2022 PLAQUETAS AGRANULARES O HIPOGRANULARES. \u2022 DE COLOR AZUL PALIDO. \u2022 DE TAMA\u00d1O HETEROG\u00c9NEO. \u2022 AGREGADOS. \u2022 AGREGACI\u00d3N AUSENTE CON ADRENALINA, DISMINUIDA CON ADP Y NORMAL CON COL\u00c1GENO. \u2022 ADHESI\u00d3N DISMINUIDA. [BERNARD - SOULIER](https://image2.slideserve.com/3848671/bernard-soulier-l.jpg) \u2022 TIEMPO DE SANGRIA PROLONGADO. \u2022 AUMENTA EL TAMA\u00d1O DE PLAQUETAS. \u2022 TROMBOCITOPENIA (50.000 \u2013 80.000/uL). \u2022 VIDA MEDIA PLAQUETARIA DISMINUIDA. \u2022 5-8u DE DIAMETRO (HASTA 20u). \u2022 ME: MAYOR CANTIDAD DE VACUOLAS CITOPLASMATICAS Y COMLPEJO DE MEMBRANA. \u2022 NO SE AGREGAN CON RISTOCETINA. [TROMBASTENIA DE GLANZMANN](https://image2.slideserve.com/3848671/trombastenia-de-glanzmann-l.jpg) \u2022 TIEMPO DE SANGRIA MUY PROLONGADO. \u2022 RECUENTO DE PLAQUETAS NORMAL. \u2022 MORFOLOGIA PLAQUETARIA NORMAL. \u2022 RETRACCI\u00d3N DEL CO\u00c1GULO DEFICIENTE \u2022 NO AGREGACI\u00d3N. [SINDROME DE HERMANSKY-PUDLAK](https://image2.slideserve.com/3848671/sindrome-de-hermansky-pudlak-l.jpg) \u2022 DEFICIENCIA DE GR\u00c1NULOS DELTA. \u2022 ASOCIADA A ALBANISMO. [SINDROME DE CH\u00c9DIAK-HIGASHI](https://image2.slideserve.com/3848671/sindrome-de-ch-diak-higashi-l.jpg) \u2022 CARACTERIZADO POR ALBANISMO. \u2022 DEFICIENCIA DE GR\u00c1NULOS DELTA. \u2022 HEMORRAGIA. [SINDROME DE WISKOT-ALDRICH](https://image2.slideserve.com/3848671/sindrome-de-wiskot-aldrich-l.jpg) TROMBOPOYESIS INEFICAZ \u2022 TROMBOCITOPENIA DESTRUCCI\u00d3N PLAQUETARIA \u2022 ESPECIALMENTE EN HOMBRES. \u2022 PLAQUETAS PEQUE\u00d1AS. [SINDROME DE PLAQUETAS GRISES](https://image2.slideserve.com/3848671/sindrome-de-plaquetas-grises-l.jpg) \u2022 AUSENCIA ESPECIFICA DE GRANULOS ALFA. \u2022 TENDENCIA DE SANGRADO LEVE. \u2022 TIEMPO DE SANGRIA PROLONGADO. \u2022 TROMBOCITOPENIA MODERADA. \u2022 PLAQUETAS GRANDES. [TRASTORNOS QUE AFECTAN LA FUNCI\u00d3N PLAQUETARIA](https://image2.slideserve.com/3848671/trastornos-que-afectan-la-funci-n-plaquetaria-l.jpg) \u2022 MIELOPROLIFERATIVOS. \u2022 MIELOMA MULTIPLE. \u2022 ENFERMEDAD HEPATICA. \u2022 UREMIA. \u2022 AFIBRINOGENEMIA.", "language": null, "image": "https://cdn2.slideserve.com/3848671/trombopatias-n.jpg", "pagetype": "article", "links": ["\\", "#", "/presentations", "/presentations", "/topics", "/updates", "/featured", "/powerpoint-templates", "/create?utm_source=slideserve&utm_medium=website&utm_campaign=presentation+creator", "/article-stories", "/online-survey", "/online-quiz", "/lead-generation", "/create?type=ebook&utm_source=slideserve&utm_medium=website&utm_campaign=ebook+creator", "https://www.slideserve.com/create?utm_source=slideserve&utm_medium=website&utm_campaign=presentation+creator", "/pro", "/upload", "/kaelem", "https://image2.slideserve.com/3848671/trombopatias-l.jpg", "https://image2.slideserve.com/3848671/anemia-apl-sica-l.jpg", "https://image2.slideserve.com/3848671/hipoplasia-megacarocitica-l.jpg", "https://image2.slideserve.com/3848671/anomalia-de-may-hegglin-l.jpg", "https://image2.slideserve.com/3848671/sindrome-tar-l.jpg", "https://image2.slideserve.com/3848671/hipoplasia-neonatal-l.jpg", "https://image2.slideserve.com/3848671/trombopoyesis-ineficaz-l.jpg", "https://image2.slideserve.com/3848671/otras-causas-l.jpg", "https://image2.slideserve.com/3848671/slide14-l.jpg", "https://image2.slideserve.com/3848671/pti-inducida-por-farmacos-l.jpg", "https://image2.slideserve.com/3848671/trombocitopenia-inducida-por-heparina-l.jpg", "https://image2.slideserve.com/3848671/slide22-l.jpg", "https://image2.slideserve.com/3848671/criterios-diagnosticos-ptt-l.jpg", "https://image2.slideserve.com/3848671/datos-de-laboratorio-l.jpg", "https://image2.slideserve.com/3848671/criterios-diagnosticos-suh-l.jpg", "https://image2.slideserve.com/3848671/datos-de-laboratorio1-l.jpg", "https://image2.slideserve.com/3848671/ahma-con-plaquetopenia-l.jpg", "https://image2.slideserve.com/3848671/trombocitosis-l.jpg", "https://image2.slideserve.com/3848671/trombocitosis1-l.jpg", "https://image2.slideserve.com/3848671/trombocitemia-esencial-l.jpg", "https://image2.slideserve.com/3848671/trombocitemia-esencial1-l.jpg", "https://image2.slideserve.com/3848671/bernard-soulier-l.jpg", "https://image2.slideserve.com/3848671/trombastenia-de-glanzmann-l.jpg", "https://image2.slideserve.com/3848671/sindrome-de-hermansky-pudlak-l.jpg", "https://image2.slideserve.com/3848671/sindrome-de-ch-diak-higashi-l.jpg", "https://image2.slideserve.com/3848671/sindrome-de-wiskot-aldrich-l.jpg", "https://image2.slideserve.com/3848671/sindrome-de-plaquetas-grises-l.jpg", "https://image2.slideserve.com/3848671/trastornos-que-afectan-la-funci-n-plaquetaria-l.jpg", "//www.slideserve.com", "//fr.slideserve.com", "/about", "/privacy", "/dmca", "https://blog.slideserve.com", "/contact", "https://www.facebook.com/SlideServe", "https://twitter.com/slideserve", "https://www.youtube.com/user/SlideServe", "https://www.pinterest.com/slideserve/"]}